FOR IMMEDIATE RELEASE
Tuesday, Feb. 8, 2011
An upcoming meeting to discuss the latest research on the mosquito-borne viral disease dengue is being jointly sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health; the Centers for Disease Control and Prevention (CDC); and the Pan American Health Organization (PAHO). Topics will span a broad spectrum of research areas including the biology and disease-causing mechanisms of dengue viruses and how they spread in communities, interact with mosquitoes, and affect the human immune system. Researchers also will present information about the most severe forms of the disease and progress being made in the development of diagnostic tests, treatments and vaccines.
The goals of the meeting are to exchange information, identify research gaps and priorities and promote future collaborations among government agencies, research institutions and universities across the Americas.
An estimated 50 to 100 million people worldwide are infected with dengue each year The disease, which is transmitted by the bites of infected mosquitoes, is endemic in the tropics and sub-tropics. Outbreaks commonly occur in the Americas, including in the U.S. Commonwealth of Puerto Rico and most recently in Florida.
Feb. 16-18, 2011, San Juan, Puerto Rico
Plenary lectures on Feb. 16 will be presented by Anthony S. Fauci, M.D., director of NIAID; Harold Margolis, M.D., chief of the Dengue Branch, Division of Vector-Borne Diseases, CDC; and Jose Luis San Martin, M.D., regional advisor for dengue, PAHO.
Media must register in advance. For more information and for media registration, contact Ann Mosher in the NIAID Office of Communications at 301-402-1663, or email@example.com.
NOTE: The meeting will NOT be Webcast. Simultaneous translation (English-Spanish) will be provided.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.
The National Institutes of Health (NIH)—The Nation's Medical Research Agency—includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
CDC protects people's health and safety by preventing and controlling diseases and injuries; provides credible information on critical health issues and promotes healthy living through strong partnerships with local, national, and international organizations.
CDC’s Division of Vector Borne-Diseases (DVBD) is responsible for protecting the American public from diseases carried by vectors—mosquitoes, ticks, and fleas. DVBD provides global leadership for dengue surveillance, diagnostics, case management, and prevention through its Dengue Branch located in Puerto Rico. For more information about CDC’s Division of Vector-Borne Diseases and its Dengue Branch, visit www.cdc.gov/dengue.
The Pan American Health Organization (PAHO) is an international public health agency with more than 100 years of experience in working to improve health and living standards of the countries of the Americas. It serves as the specialized organization for health of the Inter-American System. It also serves as the Regional Office for the Americas of the World Health Organization and enjoys international recognition as part of the United Nations system.
back to top
Last Updated February 08, 2011
Last Reviewed February 08, 2011